SCHEMBL6500392

SCHEMBL6500392

COB(O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.52
LMNA P02545 1/20 0.52
ALDH1A1 P00352 5/20 0.49
ACHE P22303 1/20 0.49
ALOX15 P16050 1/20 0.49
NFE2L2 Q16236 1/20 0.47
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
PRSS1 P07477 2/20 0.46
PRSS2 P07478 2/20 0.46
PRSS3 P35030 2/20 0.46
F2 P00734 1/20 0.46
TP53 P04637 1/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28022638 0.83 TSHR (0.52) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL27995557 0.83 TSHR (0.52) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL6683625 0.83 TSHR (0.55) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL16812678 0.81 TSHR (0.57) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL13857813 0.81 TP53 (0.50) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL29758194 0.80 TSHR (0.61) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL127723 0.80 TSHR (0.61) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL8000291 0.80 TSHR (0.47) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL2698628 0.79 PTPRC (0.45) TSHRLMNAALDH1A1ACHEALOX15
Hydrochloric Acid SCHEMBL28382242 0.79 TSHR (0.59) TSHRLMNAALDH1A1ACHEALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170015658-A1 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2017-01-19 US disclosed
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170015658-A1 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS HAVCR2, MAVS, FABP1 TSHR 1536/4885LMNA 4824/4885ALDH1A1 4382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.